Caxton Associates (New York)’s Adtran ADTN Stock Holding History
Bought
Maintained
Sold
Other funds holding ADTN
DCM
PCMI
SSA
Caxton Associates (New York)'s ADTN Position: Q4 2024 in Review
Caxton Associates (New York) opened a new position in Adtran (ADTN) in Q4 2024: 50,213 shares worth $418K. The stake represents 0.01% of the portfolio and ranks #365 among its holdings. This is a return to the name: Caxton Associates (New York) previously reported a position in ADTN as recently as Q2 2024.
Caxton Associates (New York) first reported a position in ADTN in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.18M in Q3 2023. 159 funds tracked by Wall St. Rank hold ADTN as of Q4 2024.
- Caxton Associates (New York) held 50,213 shares of Adtran worth $418K as of Q4 2024.
- Adtran was a new Caxton Associates (New York) position in Q4 2024.
- Adtran made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #365 holding.
- Caxton Associates (New York) first reported a position in Adtran in Q2 2023 and has held it in 6 quarters since.
- Caxton Associates (New York)'s Adtran position peaked at $1.18M in Q3 2023.
- 159 funds tracked by Wall St. Rank held Adtran as of Q4 2024.
Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.